The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study
2007

Impact of Cancer Drug Funding Decisions on Oncologists' Practice

Sample size: 46 publication Evidence: moderate

Author Information

Author(s): Scott Berry, Stacey Hubay, Hagit Soibelman, Douglas Martin

Primary Institution: Sunnybrook Health Sciences Centre, University of Toronto

Hypothesis

How do priority setting decisions for new cancer drugs affect oncologists' practice in Ontario?

Conclusion

Oncologists' efforts to overcome funding limits for cancer medications significantly impact their practice.

Supporting Evidence

  • Many oncologists do not accept limits on drug access imposed by funding policies.
  • Overcoming funding limits requires significant time and effort from oncologists.
  • Funding decisions impact the physician-patient relationship and discussions about treatment options.

Takeaway

Doctors want to give the best medicine to their patients, but sometimes they have to fight hard to get it because of rules about which drugs are paid for.

Methodology

Qualitative study with semi-structured, in-depth interviews.

Potential Biases

Participants may have biased views based on their experiences with the funding process.

Limitations

Findings may not be generalizable to other physicians or settings; perceptions may not reflect actual practice.

Participant Demographics

{"sex":{"female":10,"male":36},"years_practicing_oncology":{">30":4,">20":11,">10":24,"5-9":7},"country_graduated":{"Canada":39,"Europe":4,"Asia":3},"practice_details":{"group_practice":39,"solo_practice":7,"comprehensive_cancer_centre":25,"other":21,"university_hospital":24,"community_hospital":22}}

Digital Object Identifier (DOI)

10.1186/1472-6963-7-193

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication